PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.81%
Revenue growth 1.25-1.5x NXPI's 2.17%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
3.64%
Gross profit growth 1.25-1.5x NXPI's 3.04%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
4.17%
EBIT growth below 50% of NXPI's 48.41%. Michael Burry would suspect deeper competitive or cost structure issues.
5.51%
Operating income growth under 50% of NXPI's 48.41%. Michael Burry would be concerned about deeper cost or sales issues.
9.20%
Net income growth under 50% of NXPI's 165.85%. Michael Burry would suspect the firm is falling well behind a key competitor.
10.14%
EPS growth under 50% of NXPI's 160.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
9.56%
Diluted EPS growth under 50% of NXPI's 171.43%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.21%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.31%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.08%
Maintaining or increasing dividends while NXPI cut them. John Neff might see a strong edge in shareholder returns.
10.91%
OCF growth under 50% of NXPI's 44.29%. Michael Burry might suspect questionable revenue recognition or rising costs.
21.89%
FCF growth under 50% of NXPI's 51.29%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
75.75%
10Y revenue/share CAGR 1.25-1.5x NXPI's 62.21%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
22.11%
5Y revenue/share CAGR at 75-90% of NXPI's 25.94%. Bill Ackman would encourage strategies to match competitor’s pace.
9.87%
3Y revenue/share CAGR similar to NXPI's 10.40%. Walter Schloss would assume both companies experience comparable short-term cycles.
220.59%
10Y OCF/share CAGR under 50% of NXPI's 1228.23%. Michael Burry would worry about a persistent underperformance in cash creation.
63.29%
5Y OCF/share CAGR is similar to NXPI's 58.30%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
50.95%
3Y OCF/share CAGR above 1.5x NXPI's 25.04%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
255.52%
Positive 10Y CAGR while NXPI is negative. John Neff might see a substantial advantage in bottom-line trajectory.
95.58%
Positive 5Y CAGR while NXPI is negative. John Neff might view this as a strong mid-term relative advantage.
57.62%
3Y net income/share CAGR 1.25-1.5x NXPI's 44.15%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
27.78%
Equity/share CAGR of 27.78% while NXPI is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
-2.72%
Negative 5Y equity/share growth while NXPI is at 1249.87%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-6.47%
Negative 3Y equity/share growth while NXPI is at 7.11%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
601.27%
Dividend/share CAGR of 601.27% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
156.24%
Dividend/share CAGR of 156.24% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
102.09%
3Y dividend/share CAGR of 102.09% while NXPI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-5.43%
Firm’s AR is declining while NXPI shows 0.77%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-1.88%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
3.50%
Asset growth above 1.5x NXPI's 0.93%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
6.11%
BV/share growth above 1.5x NXPI's 1.57%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-0.19%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-2.82%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-5.00%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.